Literature DB >> 20887400

Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?

Eyal Shemesh, Richard N Fine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20887400      PMCID： PMC2992596          DOI： 10.1111/j.1399-3046.2010.01396.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN： 1397-3142


× No keyword cloud information.
  14 in total

1.  A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients.

Authors:  E Shemesh; S Lurie; M L Stuber; S Emre; Y Patel; P Vohra; M Aromando; B L Shneider
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

3.  Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients.

Authors:  Margaret L Stuber; Eyal Shemesh; Debra Seacord; James Washington; Gerhard Hellemann; Susan McDiarmid
Journal:  Pediatr Transplant       Date:  2008-03-04

4.  Brief report: Deficits in health care management skills among adolescent and young adult liver transplant recipients transitioning to adult care settings.

Authors:  Rachel A Annunziato; Sanobar Parkar; Christina A Dugan; Sivahn Barsade; Ronen Arnon; Tamir Miloh; Kishore Iyer; Nanda Kerkar; Eyal Shemesh
Journal:  J Pediatr Psychol       Date:  2009-12-07

5.  A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients.

Authors:  John C Bucuvalas; Frederick C Ryckman; Gajra Arya; Brandy Andrew; Anne Lesko; Conrad R Cole; Brent James; Uma Kotagal
Journal:  J Pediatr       Date:  2005-06       Impact factor: 4.406

6.  Prospective analysis of nonadherence in autoimmune hepatitis: a common problem.

Authors:  Nanda Kerkar; Rachel A Annunziato; Liberty Foley; James Schmeidler; Carolina Rumbo; Sukru Emre; Benjamin Shneider; Eyal Shemesh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-11       Impact factor: 2.839

7.  Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients.

Authors:  Eyal Shemesh; Rachel A Annunziato; Rachel Yehuda; Benjamin L Shneider; Jeffrey H Newcorn; Carolyn Hutson; Judith A Cohen; John Briere; Jack M Gorman; Sukru Emre
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 8.829

8.  Medication adherence in pediatric and adolescent liver transplant recipients.

Authors:  Eyal Shemesh; Benjamin L Shneider; Jill K Savitzky; Lindsay Arnott; Gabriel E Gondolesi; Nancy R Krieger; Nanda Kerkar; Margret S Magid; Margaret L Stuber; James Schmeidler; Rachel Yehuda; Sukru Emre
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

Review 9.  Posttraumatic stress disorder in posttransplant children: creating a clinical program to address their needs.

Authors:  Sukru Emre
Journal:  CNS Spectr       Date:  2006-02       Impact factor: 3.790

10.  An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.

Authors:  Veena L Venkat; Todd G Nick; Yu Wang; John C Bucuvalas
Journal:  Pediatr Transplant       Date:  2008-02
View more
  23 in total

Review 1.  Medical adherence in pediatric organ transplantation: what are the next steps?

Authors:  Diana A Shellmer; Annette DeVito Dabbs; Mary Amanda Dew
Journal:  Curr Opin Organ Transplant       Date:  2011-10       Impact factor: 2.640

Review 2.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

3.  Longitudinal stability of medication adherence: Trying to decipher an important construct.

Authors:  Sarah R Lieber; Eyal Shemesh
Journal:  Pediatr Transplant       Date:  2015-06

Review 4.  Monitoring drug adherence.

Authors:  Sarah R Lieber; Jacqueline Helcer; Eyal Shemesh
Journal:  Transplant Rev (Orlando)       Date:  2015-04       Impact factor: 3.943

5.  The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.

Authors:  E Shemesh; J C Bucuvalas; R Anand; G V Mazariegos; E M Alonso; R S Venick; M Reyes-Mugica; R A Annunziato; B L Shneider
Journal:  Am J Transplant       Date:  2017-04-22       Impact factor: 8.086

6.  Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.

Authors:  Sonia Solomon; Adriana Colovai; Marcela Del Rio; Nicole Hayde
Journal:  Pediatr Nephrol       Date:  2019-11-15       Impact factor: 3.714

7.  Medication adherence and rejection rates in older vs younger adult liver transplant recipients.

Authors:  Emily A Leven; Rachel Annunziato; Jacqueline Helcer; Sarah R Lieber; Christopher S Knight; Catherine Wlodarkiewicz; Rainier P Soriano; Sander S Florman; Thomas D Schiano; Eyal Shemesh
Journal:  Clin Transplant       Date:  2017-05-03       Impact factor: 2.863

Review 8.  A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect.

Authors:  S Duncan; R A Annunziato; C Dunphy; D LaPointe Rudow; B L Shneider; E Shemesh
Journal:  Pediatr Transplant       Date:  2017-12-07

9.  Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients.

Authors:  Supelana Christina; Rachel A Annunziato; Thomas D Schiano; Ravinder Anand; Swapna Vaidya; Kelley Chuang; Yelena Zack; Sander Florman; Benjamin L Shneider; Eyal Shemesh
Journal:  Liver Transpl       Date:  2014-08-26       Impact factor: 5.799

10.  Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.

Authors:  Helen P Pizzo; Robert B Ettenger; David W Gjertson; Elaine F Reed; Jennifer Zhang; H Albin Gritsch; Eileen W Tsai
Journal:  Pediatr Nephrol       Date:  2016-06-10       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.